HER2-low breast cancerHER2-low tumorshuman breast cancermetastatic breast cancerTrastuzumab deruxtecantrastuzumab-deruxtecantrastuzumabU of North TexasTrastuzumab-based treatments
… using SE-NK/Tz cells as a novel immunotherapeutic approach for HER2-low breast cancer. Our preliminary findings confirmed the targeted nature of this…